December 18, 2024
InMed Announces Results of 2024 Annual General Meeting
December 17, 2024
InMed Enters Into Standby Equity Purchase Agreement
No current content.
InMed is a leader in the manufacturing, development and commercialization of rare cannabinoids. Our manufacturing technologies produce several rare cannabinoids for pharmaceutical development and consumer products.
December 18, 2024
December 17, 2024
No current content.